A role for a new vascular enzyme in the metabolism of xenobiotic amines.
- 1 January 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 66 (1) , 249-252
- https://doi.org/10.1161/01.res.66.1.249
Abstract
Although it has long been thought that environmental toxins may play an underlying role in vascular diseases such as atherosclerosis, this concept is not supported by any clear-cut experimental evidence of toxic metabolism by cardiovascular enzymes. In this study, we demonstrate that allylamine, a selective cardiovascular toxin in vivo, is actively metabolized in vitro by a purified vascular enzyme (semicarbazide-sensitive amine oxidase), which has been localized recently to vascular smooth muscle cells. Oxidative deamination of allylamine to a highly toxic aldehyde, acrolein, was blocked through enzyme inhibition by semicarbazide-sensitive amine oxidase suggests that this vascular enzyme's physiological role may include metabolism of exogenous amines.This publication has 17 references indexed in Scilit:
- Purification of benzylamine oxidase from cultured porcine aortic smooth muscle cellsBiochemistry and Cell Biology, 1988
- Allylamine-induced vascular toxicity in vitro: Prevention by semicarbazide-sensitive amine oxidase inhibitorsToxicology and Applied Pharmacology, 1988
- In Vitro Expression of Benzylamine Oxidase Activity in Cultured Porcine Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1987
- Allylamine cardiovascular toxicityToxicology, 1987
- Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aortaJournal of Pharmacy and Pharmacology, 1985
- Amine oxidase in human blood vessels and non-vascular smooth muscleJournal of Pharmacy and Pharmacology, 1981
- Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in chicken aortas: Monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitroToxicology and Applied Pharmacology, 1980
- Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidaseToxicology, 1980
- Allylamine cardiotoxicity: I. Sequence of pathologic eventsToxicology and Applied Pharmacology, 1979
- Influence of hydralazine consumption on allylamine induced myocardial fibrosis and hypertrophy in ratsExperimental and Molecular Pathology, 1974